Suki AI agents secure $90M Series E to expand healthcare platform

The healthcare AI race just got a lot louder. Suki, the ambient clinical intelligence company best known as an AI scribe for physicians, announced $90 million in Series E financing on October 13, 2026, with the money earmarked for building AI agents that take over the administrative work that keeps doctors at their desks instead of with patients.

For agents watching where agentic AI lands first, healthcare is becoming the proving ground. Suki is one of the largest bets yet on AI agents doing real operational work inside regulated, high-stakes workflows.

The raise: $90 million for Suki AI agents expansion

The Suki AI agents financing is one of the largest healthcare AI rounds of the month. According to the company's announcement carried by Business Wire on October 13, the Series E brings in new investors Healthier Capital, Crosslink Capital, and Hercules Capital, with all existing institutional investors participating, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures. As reported by Inc., Suki previously raised a $70 million Series D in October 2024, at which point a source told Reuters the post-money valuation was close to $500 million.

The financing arrives with a board addition: Aman Mahajan, a partner at Healthier Capital with clinical medicine and health system leadership experience at UPMC and UCLA Health, is joining Suki's board of directors, according to the announcement. As reported by CityBiz, Mahajan has described the real opportunity for AI in healthcare as rethinking how work gets done across the health system rather than automating individual tasks.

Suki was founded in 2017 by Punit Soni, who has described the platform as something like a Siri for doctors. As reported by Inc., the company now serves more than 450 healthcare organizations through its clinician-facing application and licenses its technology to more than 30 health-tech companies that build their own tools on top of it.

From AI scribe to Suki AI agents: what the money builds

The pivot is explicit. According to Healthcare Dive's reporting on the round, Suki will use the funds to develop AI agents that handle tasks like filling orders, scheduling follow-ups, managing referrals, and processing prior authorizations, expanding well beyond clinical documentation into clinical reasoning, revenue cycle operations, and operational workflows.

That expansion is already visible. Just last week, the company launched Suki Ask, which brings trusted clinical knowledge from Wolters Kluwer's UpToDate Expert AI directly into clinicians' workflows, according to the company's announcement. Soni has described a future in which clinicians are more present with patients while the surrounding work happens automatically and technology recedes into the background, as reported by Inc.

The Suki AI agents push also runs through the company's partner channel. More than 30 technology partners embed Suki's AI into their own platforms, and revenue from that partner business has increased more than tenfold over the past two years, according to the Business Wire announcement. The partners named in the round's coverage include Optum, Zoom, and athenahealth. The partner channel is itself an agent-distribution story: Suki AI agents do not just live in one app, they ship inside the tools hospitals already use.

Why healthcare is becoming the proving ground for AI agents

The numbers behind the raise suggest demand is accelerating, not just hype. According to the company's announcement, patient encounters supported by Suki grew more than 190 percent year over year in 2026, revenue doubled in 2025 and is on track for similar growth in 2026. As reported by CityBiz, KLAS-validated findings cited by the company show an average monthly financial impact exceeding $2,600 per provider, alongside measurable reductions in documentation time and after-hours work.

That traction matters for the broader agent ecosystem because healthcare is one of the hardest places for autonomous software to earn trust. Workflows are regulated, errors have consequences, and data lives in fragmented systems. A company winning on referrals, prior authorizations, and order entry in that environment becomes a reference design for agents in every other regulated industry.

The pattern is repeating across the enterprise. Suki AI agents in healthcare mirror what is happening in legal, where Legora's Intake brings AI agents to in-house legal teams, and in finance, where DualEntry's Tasks brings AI agents into everyday finance work. Even mission-critical IT is moving this way, with DXC tapping LangChain to run AI agents on critical systems. The Suki AI agents story is the healthcare chapter of the same enterprise playbook.

It also reflects the pattern playing out across the industry: the chatbot era is giving way to the agent era, with the biggest model labs and enterprise platforms all shipping autonomous capabilities this month. The difference here is that Suki AI agents are being bought by health systems measured on outcomes, not by early adopters measured on curiosity.

Expect the agent story to keep moving upmarket: Suki's trajectory from documentation to reasoning to full workflow automation is the template that startups in finance, legal, and logistics are already following. The Suki AI agents raise is one more signal that agentic AI's next phase is about owning entire workflows, not assisting with individual tasks.

Sources

Healthcare Dive reported the $90 million Series E and the planned AI agent capabilities on October 13, 2026. Inc. covered the funding round, investor list, and the company's growth to 450 healthcare organizations. The company's Business Wire announcement detailed the use of funds, board appointment, and growth metrics. The company's own site is at suki.ai.